the market has an unfavorable view of bio techs right now, anp keeps talking about getting partnered up for their drugs that are in trials and they have not produced a partner yet and the market sees this and its showing in the share price. anp has 2 pretty good drug prospects. I like stocks like this that are out of favor with the market. if anp does a cr and the sp dips more I will add to my position. this stock imo has more upside potential than downside risk. you have to be realistic though that the company needs funds very shortly and a cr is a definite possibility.
the market has an unfavorable view of bio techs right now, anp...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $94.66M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 10.5¢ | $35.58K | 335.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 375558 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 41673 | 2 |
View Market Depth
| Last trade - 11.01am 18/09/2024 (20 minute delay) ? |
| PER (ASX) Chart |